SCHEMBL22434

SCHEMBL22434

[CH2]CCC1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866084 0.97 CYP1A2 (0.48)
SCHEMBL60593 0.97
SCHEMBL21831394 0.97 CYP1A2 (0.48)
SCHEMBL178170 0.97 CYP1A2 (0.48)
SCHEMBL866633 0.97 CYP1A2 (0.48)
SCHEMBL867086 0.97 CYP1A2 (0.48)
SCHEMBL21831579 0.97 CYP1A2 (0.48)
SCHEMBL21114318 0.97 CYP1A2 (0.48)
SCHEMBL8176343 0.97 CYP1A2 (0.48)
SCHEMBL3027711 0.97 CYP1A2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5669 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207253-A1 Inhibitors of CDR1 for Reversal of Azole Drug Resistance in Fungal Infections THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-06-27 US claimed
EP-3901147-B1 ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2023-11-22 EP claimed
CN-116903480-A Method for preparing beta-enaminone based on sulfoxide and aldoxime and beta-enaminone 盐城师范学院 2023-10-20 CN claimed
CN-116848094-A Tertiary amine lipid compounds and uses thereof 华南理工大学 2023-10-03 CN claimed
WO-2023125184-A1 TERTIARY AMINE LIPID COMPOUND AND USE THEREOF 华南理工大学 2023-07-06 WO claimed
US-20230026425-A1 ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2023-01-26 US claimed
WO-2022245951-A1 INHIBITORS OF CDR1 FOR REVERSAL OF AZOLE DRUG RESISTANCE IN FUNGAL INFECTIONS UNM RAINFOREST INNOVATIONS (US) 2022-11-24 WO claimed
CN-108794423-B Urea derivatives 鲁南制药集团股份有限公司 2022-07-19 CN claimed
CN-112442045-B Acyl-substituted oxazine quinazoline compound, preparation method and application thereof 北京赛特明强医药科技有限公司 2022-02-18 CN claimed
CN-111233786-B Benzene sulfonamide compound containing five-membered heterocycle and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2021-11-26 CN claimed
WO-1992004021-A1 METHOD FOR PROVIDING IMPROVED ANALGESIC EFFECT RICHARDSON VICKS INC. (US) 1992-03-19 WO claimed
WO-1992000278-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1992-01-09 WO claimed
EP-0419963-A2 1,2,3,4-Tetrahydro-5-nitropyrimidine derivatives BAYER AG (DE) 1991-04-03 EP claimed
EP-0397427-A1 Fluoro-amide derivatives having human leucocyte elastase inhibiting activity ZENECA INC. (US) 1990-11-14 EP claimed
EP-0259752-A2 Saccharide phosphates, their esters and method for their preparation BAYER AG (DE) 1988-03-16 EP claimed
US-4593090-A Containing perhydrofuran or pyran ring structure GOGO KIMURA (JP) 1986-06-03 US claimed
EP-0179619-A1 Heterocyclic amides ICI AMERICAS INC. (US) 1986-04-30 EP claimed
US-4089865-A Certain thiazole compounds SYNTEX (U.S.A.) INC. (US) 1978-05-16 US claimed
US-4088772-A TRANQUILIZERS, ANALGESICS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-05-09 US claimed
US-4001421-A THIAZOLE CARDIOVASCULAR AGENTS SYNTEX (U.S.A.) INC. (US) 1977-01-04 US claimed